Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy.
D000818:Animals; D000951:Antigens, Neoplasm; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007106:Immune Sera; D007110:Immunity, Active; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007158:Immunologic Techniques; D007167:Immunotherapy; D008221:Lymphoid Tissue / Q000276:immunology; D008297:Male; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012334:RNA, Neoplasm / Q000276:immunology
D000951:Antigens, Neoplasm; D007106:Immune Sera; D012334:RNA, Neoplasm